Antioxidant and Hepatoprotective Effects of Naringenin and Its β-Cyclodextrin Formulation in Mice Intoxicated with Carbon Tetrachloride: A Comparative Study
Restricted accessResearch articleFirst published online June, 2014
Antioxidant and Hepatoprotective Effects of Naringenin and Its β-Cyclodextrin Formulation in Mice Intoxicated with Carbon Tetrachloride: A Comparative Study
The present study evaluated the antioxidant and hepatoprotective effects of the flavonoid naringenin (NGN) and its β-cyclodextrin formulation at a dose of 50 mg/kg b.w. The assessment was done by the investigation of serum-enzymatic and liver antioxidant activity, histopathological and ultrastructural changes in male Swiss mice, which were subjected to acute experimental intoxication with CCl4. Formulated and free flavonoid were orally given to mice for 7 days and then were intraperitoneally injected with 1.0 mL/kg CCl4 on the 8th day. After 24 h of CCl4 administration, an increase in the levels of transaminases aspartate aminotransferase and alanine aminotransferase activities and malondialdehyde concentration occurred and a significant decrease in superoxide dismutase, catalase glutathione-peroxidase activities, and glutathione levels was detected as well. These were accompanied by extended centrilobular necrosis, steatosis, fibrosis, and an altered ultrastructure of hepatocytes. Pretreatment with formulated or free flavonoid retained the biochemical markers to control values. Histopathological and electron-microscopic examination confirmed the biochemical results. In conclusion, both NGN and NGN/β-cyclodextrin complex showed antioxidant and hepatoprotective effects against injuries induced by CCl4.
TanikawaK, TorimuraT: Studies on oxidative stress in liver diseases: important future trends in liver research. Med Mol Morphol, 2006; 39:22–27.
3.
VidelaLA: Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol, 2009; 1:72–78.
4.
NijveldtRJ, van NoodE, van HoornDEC, BoelensPG, van NorrenK, van LeeuwenPAM: Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr, 2001; 74:418–425.
5.
RenugadeviJ, PrabuSM: Cadmium–induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol, 2010; 62:171–181.
6.
PrabuSM, ShagirthaK, RenugadeviJ: Naringenin in combination with vitamin C and E potentially protects oxidative stress–mediated hepatic injury in cadmium-intoxicated rats. J Nutr Sci Vitaminol, 2011; 57:177–185.
7.
JainA, YadavA, BozhkovAI, PadalkoVI, FloraSJS: Therapeutic efficacy of silymarin and naringenin in reducing arsenic–induced hepatic damage in young rats. Ecotoxicol Environ Safe, 2011; 77:607–614.
8.
WangJ, YangZ, LinL, ZhaoZ, LiuZ, LiuX: Protective effect of naringenin against lead–induced oxidative stress in rats. Biol Trace Elem Res, 2012; 146:354–359.
9.
LeeMH, YoonS, MoonJO: The flavonoid naringenin inhibits dimethylnitrosamine–induced liver damage in rats. Biol Pharm Bull, 2004; 27:72–76.
10.
PariL, GnansoundariM: Influence of naringenin on oxytetracycline mediated oxidative damage in rat liver. Basic Clin Pharmacol, 2006; 98:456–461.
11.
LeonardyT, VanamalaJ, TaddeoS, DavidsonLA, MurphyME, PatilBS, WangN, CarrollRJ, ChapkinRS, LuptonJR, TurnerND: Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane–treated rats. Exp Biol Med, 2010; 235:710–717.
QinL, JinL, LuL, LuX, ZhangC, ZhangF, LiangW: Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell, 2011; 2:507–516.
14.
SoromouLW, ZhangZ, LiR, ChenN, GuoW, HuoM, GuanS, LuJ, DengX: Regulation of inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 murine macrophage by 7-0- methyl-naringenin. Molecules, 2012; 17:3574–3585.
15.
RibeiroIA, RochaJ, SepodesB, Mota-FilipeH, RibeiroMH: Effects of naringenin enzymatic hydrolysis towards naringenin on the anti-inflamatory activity of both compounds. J Mol Catal B Enzym, 2008; 52–53:13–18.
16.
BodetC, LaVD, EpifanoF, GrenierD: Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. J Periodont Res, 2008; 43:400–407.
17.
HamalainenM, NieminenR, VuorelaP, HeinonenM, MoilanenE: Anti-inflamatory effects of flavonoids: genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-kB activations, whereas flavone, isorhamnetin, naringenin and pelargonidin inhibit only NF-kB activation along their inhibitory effect of iNOS expression and NO production in activated macrophages. Mediat Inflamm, 2007; 2007:45673.
18.
DennyBJ, WestPWJ, MathewTC: Antagonistic interactions between the flavonoids hesperetin and naringenin and β-lactam antibiotics against Staphylococcus aureus. Br J Biomed Sci, 2008; 65:145–147.
19.
GoldwasserJ, CohenPY, LinW, KitsbergD, BalaguerP, PolyakSJ, ChungRT, YarmushML, NahmiasY: Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol, 2011; 55:963–971.
20.
NahmiasY, GoldwasserJ, CasaliM, van PollD, WakitaT, ChungRT, YarmushML: Apolipoprotein B-dependent Hepatitits C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology, 2008; 47:1437–1445.
21.
Ortiz-AndradeRR, Sanchez-SalgadoJC, Navarrete-VasquezG, WebsterSP, BinnieM, Garcia-JimenezS, Leon-RiveraI, Igarroa-VasquezPC, Villalobos-MolinaR, Estrada-SotoS: Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab, 2008; 10:1097–1104.
22.
HanX, PanJ, RenD, ChengY, FanP, LouH: Naringenin-7-0-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem Toxicol, 2008; 46:3140–3146.
23.
HeoHJ, KimDO, ShinSC, KimMJ, KimBG, ShinDH: Effect of antioxidant flavonone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem, 2004; 52:1520–1525.
24.
SinghD, ChanderV, ChopraK: Protective effects of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology, 2004; 201:143–151.
25.
RenugadeviJ, PrabuSM: Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology, 2009; 256:128–134.
26.
HsiuSL, HuangTY, HouYC, ChinDH, ChaoDP: Comparison of metabolic pharmacokinetics of naringenin and naringenin in rabbits. Life Sci, 2002; 70:1481–1489.
27.
YenFL, WuTH, LinLT, ChamTM, LinCC: Naringenin–loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm Res, 2009; 26:893–902.
28.
ShulmanM, CohenM, Soto-GutierrezA, YagiH, WangH, GoldwasserJ, Lee-ParsonsCW, Benny-RatsabyO, YarmushML, NahmiasY: Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropyl-b-Cyclodextrin. PLoS One, 2011; 6:e18033.
29.
MaitiK, MukherjeeK, GantaitA, SahaBP, MukherjeePK: Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Parmacol, 2008; 58:1227–1233.
30.
HadarugaDI, HadarugaNG, BandurG, IsengardHD: Water content of flavonoid/cyclodextrin nanoparticles: relationship with the structural descriptors of biologically active compounds. Food Chem, 2012; 132:1651–1659.
Europe Co: Appendix A of the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS No. 123). Cons 123, 3rd edition, 2006.
35.
AebiH: Catalase. In: Methods of Enzymatic Analysis (BergmeyerHU, ed.). Academic Press, New York, NY, 1974, pp. 673–677.
36.
PaolettiF, MocaliA: Determination of superoxide dismutase activity by purely chemical system based on NADP(H) oxidation. Methods Enzymol, 1990; 186:209–221.
37.
BeutlerE: Red cell metabolism. In: A Manual of Biochemical Methods (BeutlerE, ed.). Grune and Stratton, Orlando, FL, 1984, pp. 68–73.
38.
Del RioD, PellegriniN, ColombiB, BianchiM, SerafiniM, TortaF, TegoniF, MusciM, BrighentiF: Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem, 2003; 49:690–692.
39.
LowryOH, Rosebrough NJ FarrAL, RandallRJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193:265–275.
WeberLW, BollM, StampflA: Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol, 2003; 33:105–136.
42.
BolarinDM: Serum bile acid in the evaluation of colchicines treatment of carbon tetrachloride-induced liver injury. Exp Mol Pathol, 1984; 41:384–389.
43.
ChetiaP, BalaA, KhandelwalB, HaldarPK: Comparative in vitro free radical scavenging property of β-carotene and naringenin with respect to vitamin C and N-acetyl Cysteine. Pharmacologia, 2012; 3:724–728.
44.
MoskaugJO, CarlsenH, MyhrstadMC, BlomhoffR: Polyphenols and glutathione synthesis regulation. Am J Clin Nutr, 2005; 81:277S-283S.
45.
TownsendDM, TewKD, TapieroH: The importance of glutathione in human disease. Biomed Pharmacother, 2003; 57:145–155.
46.
YuanLP, ChenFH, LingL, BoH, ChenZW, LiF, ZhongMM, XiaLJ: Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride induced liver fibrosis in rats. J Pharm Pharmacol, 2008; 60:1393–1402.
47.
de Oliveira e SilvaAM, Vidal-NovoaA, Batista-GonzálesAE, PintoJR, Portari ManciniDA, Reina-UrquijoW, Marccini-FilhoJ: In vivo and in vitro antioxidant activity and hepatoprotective properties of polyphenols from Halimeda opuntia (Linnaeus). Redox Rep, 2012; 17:47–53.
48.
YingCJ, SunXF, ZhangSL, ZhangXP, MaoLM, ZuoXZ, YaoP: ROS-related enzyme expressions in endothelial cells regulated by tea polyphenols. Biomed Environ Sci, 2004; 17:33–39.
49.
Andrade BeloMA, SoaresVE, SouzaLM, Rosa SobreiraMF, Silveira CassolDM, Barioni TomaS: Hepatoprotective treatment attenuates oxidative damages induced by carbon tetrachloride in rats. Exp Toxicol Pathol, 2012; 64:155–165.
50.
HermeneanA, PopescuC, ArdeleanA, StanM, HadarugaN, MihaliCV, CostacheM, DinischiotuA: Hepatoprotective effect of Berberis vulgaris L. extract/beta-cyclodextrin on carbon tetrachloride–induced acute toxicity in mice. Int J Mol Sci, 2012; 13:9014–9934.
51.
TasciI, MasN, MasMR, TuncerM, ComertB: Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury. World J Gastroenterol, 2008; 14:4897–4902.
52.
SongIM, LeeYM, ChungSJ, ShimCK: Multiple alterations of canalicular membrane transport activities in rats with CCl4-induced hepatic injury. Drug Metab Dispos, 2003; 31:482–490.
